Literature DB >> 12905012

An unspecific immunostimulating agent and juvenile dermatomyositis: enhanced T-cell proliferation and reverse immunosuppression as a severe adverse drug reaction.

Gerd M Lackmann1, Jenny Ndagijimana, Tim Niehues.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12905012     DOI： 10.1007/s00431-003-1290-z

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  3 in total

1.  New-onset juvenile dermatomyositis: comparisons with a healthy cohort and children with juvenile rheumatoid arthritis.

Authors:  L M Pachman; J R Hayford; M C Hochberg; M A Pallansch; A Chung; C D Daugherty; B H Athreya; S L Bowyer; C W Fink; H L Gewanter; R Jerath; B A Lang; I S Szer; J Sinacore; M L Christensen; A R Dyer
Journal:  Arthritis Rheum       Date:  1997-08

2.  Methyl inosine monophosphate (MIMP) augments T-lymphocyte mitogen responses and reverses various immunosuppressants.

Authors:  E M Hadden; Y Wang; M Sosa; R G Coffey; A Giner-Sorolla; J W Hadden
Journal:  Int J Immunopharmacol       Date:  1995-09

Review 3.  Immune manifestations of inflammatory muscle disease.

Authors:  I N Targoff
Journal:  Rheum Dis Clin North Am       Date:  1994-11       Impact factor: 2.670
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.